Disetronic is an international supplier of medical devices for the treatment of diabetes. The company is one of the world's leading manufacturers of insulin pumps for people with diabetes. Roche is now majority shareholder of Disetronic, whose shares have been trading on the Swiss Stock Exchange SWX since 1996. Disetronic's product development and production is located in Burgdorf, Switzerland, with two additional production plants in Germany and the United States, and is directly represented through its own sales and distribution companies in Europe and North America. Disetronic employs 830 people worldwide.
Insulin Pumps
Disetronic is the world's leading supplier of infusion systems for the treatment of Type I diabetes. The three programmable insulin pumps produced by Disetronic allow patients to continuously administer insulin doses according to their individual needs. This means that the treatment can be optimized in physiological terms and that patients enjoy a better quality of life than with conventional treatments.
Micro-Dosage Pumps
In the area of ADDS (Advanced Drug Delivery Systems), Disetronic offers various types of micro-dosage pumps for the infusion of medication in small and large volumes.
Accessories
Disetronic supplies a wide range of accessories, such as sterile consumer products (infusion sets, cartridges), batteries and carrying systems.